Vimpat 150mg Tablets - blister strips are incorrectly labelled

(OPD Laboratories Limited) Recall as some packs have incorrectly-labelled blister strips – class 2 action within 48 hours. (EL (13)A/01)

08 January 2013

Class 2 medicines recall

Action within 48 hours

Pharmacy, clinic and wholesaler-level recall

MDR 03-01/13

Product details

OPD Laboratories Limited

Vimpat 150mg Tablets

(Lacosamide)

EU/1/08/470/008

Alert details

Batch number   Expiry date   Pack size   First distributed
8351104/4   January 2015   56 tablets   11 October 2012

OPD Laboratories Ltd is recalling all remaining packs of the above batch of this parallel distributed product due to a labelling error. The blister strips are incorrectly labelled as 50mg but the cartons are correctly labelled as 150mg.

Any remaining stock of this batch should be quarantined and returned to the original supplier for credit. For enquiries relating to stock returns, please call Mr Anthony Joseph on 01923 332746.

For medical information enquiries, please call Mrs Gail Friend on 01923 332796.

Recipients of this drug alert should bring it to the attention of relevant contacts by copy of this letter. Primary care trusts are asked to forward this to relevant clinics and to general practitioners and community pharmacists for information.

MHRA distribution

Further recipients by cascade:

Regional contacts for NHS trusts and provider units
Chief pharmacists: England, Scotland, Wales, Northern Ireland
Prison health policy unit (DH)
Chief pharmacists:  Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar
Special hospitals
Healthcare commission for distribution to independent health care establishments
Primary care trusts (England)

Download documents

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.